Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,868 | 853 | 99.8% |
| Education | $25.57 | 5 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,809 | 99 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,774 | 112 | $0 (2024) |
| Novo Nordisk Inc | $1,416 | 90 | $0 (2024) |
| ABBVIE INC. | $1,269 | 77 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,072 | 59 | $0 (2024) |
| Merck Sharp & Dohme LLC | $638.29 | 50 | $0 (2023) |
| PFIZER INC. | $621.92 | 46 | $0 (2024) |
| Lilly USA, LLC | $615.48 | 41 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $572.44 | 31 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $437.43 | 33 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,510 | 82 | AstraZeneca Pharmaceuticals LP ($268.44) |
| 2023 | $1,863 | 98 | GlaxoSmithKline, LLC. ($282.49) |
| 2022 | $2,315 | 126 | Boehringer Ingelheim Pharmaceuticals, Inc. ($407.59) |
| 2021 | $1,777 | 105 | AbbVie Inc. ($280.00) |
| 2020 | $848.52 | 53 | Boehringer Ingelheim Pharmaceuticals, Inc. ($265.85) |
| 2019 | $1,956 | 134 | Novo Nordisk Inc ($245.84) |
| 2018 | $1,776 | 126 | GlaxoSmithKline, LLC. ($280.53) |
| 2017 | $1,848 | 134 | GlaxoSmithKline, LLC. ($296.68) |
All Payment Transactions
858 individual payment records from CMS Open Payments — Page 1 of 35
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: DIABETES | ||||||
| 12/13/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/06/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.41 | General |
| Category: Respiratory | ||||||
| 12/04/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: UROLOGY | ||||||
| 12/02/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: RESPIRATORY | ||||||
| 11/13/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.71 | General |
| Category: Cardiovascular | ||||||
| 11/08/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/06/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $12.31 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $7.62 | General |
| Category: RESPIRATORY | ||||||
| 11/05/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: Respiratory | ||||||
| 11/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.12 | General |
| Category: Cardio-renal | ||||||
| 11/01/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: Diabetes Care | ||||||
| 10/28/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: Diabetes | ||||||
| 10/24/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: Diabetes Care | ||||||
| 10/23/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: Oncology | ||||||
| 10/22/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: RESPIRATORY | ||||||
| 10/18/2024 | Renalytix AI, Inc. | KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT (Device) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/14/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $18.20 | General |
| 10/07/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $20.90 | General |
| 10/04/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $27.80 | General |
| Category: Neuropsychiatry | ||||||
| 09/27/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: Diabetes Care | ||||||
| 09/26/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: Oncology | ||||||
| 09/24/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: Obesity | ||||||
| 09/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 34 | 2,016 | 2,489 | $164,491 | $75,293 |
| 2022 | 37 | 2,155 | 2,582 | $186,208 | $79,244 |
| 2021 | 35 | 2,018 | 2,393 | $185,898 | $58,727 |
| 2020 | 32 | 2,303 | 2,698 | $195,704 | $65,471 |
All Medicare Procedures & Services
138 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 174 | 174 | $30,450 | $21,487 | 70.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 122 | 196 | $27,636 | $11,498 | 41.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 118 | 131 | $27,510 | $10,444 | 38.0% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 16 | 16 | $6,708 | $4,502 | 67.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 55 | 55 | $6,325 | $3,956 | 62.5% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 19 | 55 | $7,700 | $3,042 | 39.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 262 | 357 | $7,140 | $2,999 | 42.0% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 145 | 157 | $6,257 | $2,060 | 32.9% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 155 | 182 | $5,824 | $1,884 | 32.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 60 | 60 | $3,300 | $1,771 | 53.7% |
| 82306 | Vitamin d-3 level | Office | 2023 | 52 | 52 | $4,264 | $1,509 | 35.4% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 154 | 194 | $4,656 | $1,476 | 31.7% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 70 | 77 | $3,696 | $1,267 | 34.3% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 78 | 104 | $3,120 | $990.08 | 31.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 22 | 26 | $2,210 | $934.21 | 42.3% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 20 | 21 | $2,100 | $727.02 | 34.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 55 | 61 | $3,355 | $493.11 | 14.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 16 | 16 | $880.00 | $472.16 | 53.7% |
| 87086 | Bacterial colony count, urine | Office | 2023 | 36 | 56 | $1,400 | $442.96 | 31.6% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 26 | 27 | $1,134 | $399.06 | 35.2% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 12 | 24 | $816.00 | $389.28 | 47.7% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 19 | 19 | $969.00 | $359.48 | 37.1% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 57 | 110 | $1,100 | $349.89 | 31.8% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 33 | 36 | $900.00 | $298.44 | 33.2% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 42 | 45 | $810.00 | $254.70 | 31.4% |
About Saaket Gupta
Saaket Gupta is a Internal Medicine healthcare provider based in Schenectady, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1336229392.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Saaket Gupta has received a total of $13,893 in payments from pharmaceutical and medical device companies, with $1,510 received in 2024. These payments were reported across 858 transactions from 53 companies. The most common payment nature is "Food and Beverage" ($13,868).
As a Medicare-enrolled provider, Gupta has provided services to 8,492 Medicare beneficiaries, totaling 10,162 services with total Medicare billing of $278,736. Data is available for 4 years (2020–2023), covering 138 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Schenectady, NY
- Active Since 10/16/2006
- Last Updated 10/10/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1336229392
Products in Payments
- TRELEGY ELLIPTA (Drug) $1,168
- JARDIANCE (Drug) $880.77
- TRADJENTA (Drug) $640.24
- FARXIGA (Drug) $597.09
- UBRELVY (Drug) $479.45
- Ozempic (Drug) $460.59
- JANUVIA (Drug) $392.62
- ANORO (Drug) $346.97
- SOLIQUA 100/33 (Biological) $324.89
- TRULICITY (Drug) $298.64
- XARELTO (Drug) $289.95
- CHANTIX (Drug) $285.79
- QULIPTA (Drug) $264.09
- Vascepa (Drug) $237.99
- Victoza (Drug) $227.51
- AIRSUPRA (Drug) $215.68
- STIOLTO RESPIMAT (Drug) $204.61
- VRAYLAR (Drug) $201.01
- ENTRESTO (Drug) $198.50
- Saxenda (Drug) $192.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Schenectady
Dr. Ahmed Khan, Md, MD
Internal Medicine — Payments: $44,956
Dr. Abul Azad, Md, MD
Internal Medicine — Payments: $34,573
Niraj Sinha, M.d, M.D
Internal Medicine — Payments: $13,154
George Vassolas, Md, MD
Internal Medicine — Payments: $6,513
Dr. Peter Rienzi, M.d, M.D
Internal Medicine — Payments: $5,513
Sergey Gorbachev, Md, MD
Internal Medicine — Payments: $4,913